Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
Researchers identify two adult cancer medications which have the potential to improve treatment for medulloblastoma brain cancer in children.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.
Researchers discover glioblastoma brain tumor cells disrupt the blood brain barrier. The findings offer potential new avenues to treat brain cancer.
A pioneering ultrasound treatment could help treat hypothalamic hamartomas, a rare, benign mass in the brain that can cause epilepsy symptoms and unintentional giggling seizures.
Researchers report an experimental treatment has shown to be able to stop treatment resistant glioblastoma in human cells and mouse models.
Researchers identify the most common genetic alteration in ependymoma brain tumors.
According to researchers, new evidence suggest survivors of childhood cancers have higher risk of suffering a stroke at a young age.